Team:Paris Bettencourt

From 2013.igem.org

(Difference between revisions)
 
(11 intermediate revisions not shown)
Line 211: Line 211:
   <div id="topheader">
   <div id="topheader">
-
     <img style="margin-top:-1px" src="https://static.igem.org/mediawiki/2013/c/c8/PB_frontpagebanner.png" width="1100px" height="632"/>
+
     <img style="margin-top:-1px" src="https://static.igem.org/mediawiki/2013/0/0a/PB_frontpagebanner7.png" width="1100px" height="632"/>
     <img id="BotArrow" src="https://static.igem.org/mediawiki/2013/7/7d/PB_Banner_Lines2.gif" width="1100px">
     <img id="BotArrow" src="https://static.igem.org/mediawiki/2013/7/7d/PB_Banner_Lines2.gif" width="1100px">
     <img id="PBlogo" src="https://static.igem.org/mediawiki/2013/3/3a/PB_logoParis.gif" width="122px"/>
     <img id="PBlogo" src="https://static.igem.org/mediawiki/2013/3/3a/PB_logoParis.gif" width="122px"/>
Line 225: Line 225:
    <div class="cont">
    <div class="cont">
      <p style="font-size:26px;">
      <p style="font-size:26px;">
-
Tuberculosis (TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> (Mtb) that affects nearly two billion people around the world. On this website we present four new ways to use the power of synthetic biology in the fight against TB: from gene detection, to drug targeting, to infiltrating macrophages, to sabotaging the synthesis of proteins. Click this panel to see our project overview.
+
Tuberculosis (TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> (Mtb) that affects nearly two billion people around the world. On this website we present four new ways to use the power of synthetic biology in the fight against TB: from gene detection, to drug targeting, to infiltrating macrophages, to sabotaging the synthesis of proteins. Hover over these panels to see the project overview.
      </p>
      </p>
    </div>
    </div>
Line 240: Line 240:
    <div id="thdesc" class="spdesc">
    <div id="thdesc" class="spdesc">
      <div class="cont">
      <div class="cont">
-
<p style="font-size:26px;">A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.</p>
+
<p style="font-size:26px;">A phage system with low fitness cost producing sRNA, which inhibits the synthesis of antibiotic resistance proteins.</p>
      </div>
      </div>
    </div>
    </div>
Line 293: Line 293:
       <a href="https://2013.igem.org/Team:Paris_Bettencourt/Results" title="Results">
       <a href="https://2013.igem.org/Team:Paris_Bettencourt/Results" title="Results">
<div class="subpanel3" >
<div class="subpanel3" >
-
  <img width="70px" style="margin-left:120px;margin-right:15px;position:relative;bottom:1px" src="https://static.igem.org/mediawiki/2013/d/d5/PB_handresults.gif"/>Results page
+
  <img width="70px" style="margin-left:80px;margin-right:15px;position:relative;bottom:1px" src="https://static.igem.org/mediawiki/2013/d/d5/PB_handresults.gif"/>Jump to Results
</div>
</div>
       </a>
       </a>

Latest revision as of 14:06, 6 November 2013

Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
+33 1 44 41 25 22/25
team2013@igem-paris.org
Hit Counter by Digits
Copyright (c) 2013 igem.org. All rights reserved.